Back to
VANGUARD GROUP INC
MYGN6 quarters
Position history for
VANGUARD GROUP INC's holdings in MYRIAD GENETICS INC
As of its last 13F, for Q4 2025, Vanguard Group held 8,225,371 shares of MYGN (Myriad Genetics), worth $50.6M. It increased the position by 342,856 shares (+4.4%) from Q3 2025. Vanguard Group held MYGN from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.
Current Value
$50.6M
Current Shares
8.2M
Total Value Change
-$231.9M
Total Shares Change
-2.1M
Quarter-by-Quarter History
Other major holders of MYGN: BlackRock, Inc., BlackRock Finance, Inc., BAILLIE GIFFORD & CO